ADIPOQ and endometrial cancer: Our main objective was to evaluate the levels of adiponectin, leptin, TNFα, IL6, and IGFs 1 and 2 in endometrial cancer patients compared to control patients with benign gynaecological conditions and to assess their relationship with obesity using the WHO BMI classification [57].